Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Long Term DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CureVac N.V (CVAC) Receivables - Net: 2019-2024

Historic Receivables - Net for CureVac N.V (CVAC) over the last 6 years, with Dec 2024 value amounting to $15.0 million.

  • CureVac N.V's Receivables - Net fell 97.71% to $462,971 in Q2 2025 from the same period last year, while for Jun 2025 it was $462,971, marking a year-over-year decrease of 97.71%. This contributed to the annual value of $15.0 million for FY2024, which is 2.41% down from last year.
  • As of FY2024, CureVac N.V's Receivables - Net stood at $15.0 million, which was down 2.41% from $15.4 million recorded in FY2023.
  • Over the past 5 years, CureVac N.V's Receivables - Net peaked at $21.2 million during FY2021, and registered a low of $1.2 million during FY2020.
  • For the 3-year period, CureVac N.V's Receivables - Net averaged around $12.3 million, with its median value being $15.0 million (2024).
  • In the last 5 years, CureVac N.V's Receivables - Net crashed by 93.04% in 2020 and then surged by 1,650.90% in 2021.
  • CureVac N.V's Receivables - Net (Yearly) stood at $1.2 million in 2020, then surged by 1,650.90% to $21.2 million in 2021, then crashed by 69.66% to $6.4 million in 2022, then soared by 140.00% to $15.4 million in 2023, then dropped by 2.41% to $15.0 million in 2024.